News in other languages : Biosynex

Aug. 07	Bourse : Eutelsat souffre, la tech américaine s'offre un baroud d'honneur nocturne
Aug. 07	L'énigmatique Mister Warsh, le marché du travail et les taux
Aug. 06	Biosynex victime d'une cyberattaque, l'activité opérationnelle préservée
Aug. 06	BIOSYNEX SA: Cyberattaque
Jul. 22	BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2026 : 44,1 M€ - PERSPECTIVES

More news

Managers and Directors : Biosynex

Manager	Title	Age	Since
Larry Abensur CEO	Chief Executive Officer	71	2015-06-23
Thierry Paper CTO	Chief Tech/Sci/R&D Officer	63	2014-12-31
Oren Bitton PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Thierry Paper BRD	Director/Board Member	63	2015-06-23
Thomas Lamy BRD	Director/Board Member	-	2015-06-23
Larry Abensur CHM	Chairman	71	2015-06-23

More insiders

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOSYNEX	-0.45%	-0.89%	-23.59%	-91.58%	19.22M
GUARDANT HEALTH, INC.	-1.54%	-2.55%	+139.09%	+306.91%	21.34B
BIOMÉRIEUX	+0.87%	+0.26%	-35.79%	-20.00%	10.26B
10X GENOMICS, INC.	+1.48%	-2.12%	+367.09%	+20.44%	8.14B
CARIS LIFE SCIENCES, INC.	-0.55%	-2.45%	-30.28%	-	7.2B
LANTHEUS HOLDINGS, INC.	+0.19%	+0.16%	+82.60%	+47.52%	6.59B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.28%	-3.74%	-20.01%	-17.76%	5.83B
ANDON HEALTH CO., LTD.	+3.67%	-0.50%	+78.06%	+87.05%	4.39B
DIASORIN S.P.A.	+1.95%	+2.49%	-9.39%	-20.71%	4.36B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.45%	-4.86%	-18.86%	-29.13%	2.8B
Average	+0.09%	-0.68%	+52.89%	+31.42%	7.09B
Weighted average by Cap.	-0.23%	-1.01%	+85.23%	+108.72%

See all sector performances

Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.

Employees

397

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-09-01	€0.8940	-0.45%	6,206
26-08-31	€0.8980	-0.22%	2,129
26-08-28	€0.9000	-2.17%	3,237
26-08-27	€0.9200	+2.68%	17,041
26-08-26	€0.8960	-0.67%	4,358

Real-time Euronext Paris

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Real-time Euronext Paris 05:59:42 2026-09-01 am EDT			5-day change	1st Jan Change
0.8940 ^EUR	-0.45%		-0.89%	+50.00%

Aug. 06	Biosynex hit by cyberattack, operational activity remains intact
Jun. 11	Triple update for Biosynex

Market Cap	16.55M 19.22M 15.54M 14.19M 26.65M 1.83B 26.84M 184M 71.65M 928M 72.18M 70.61M 3.07B	P/E 2024	-0.43x	P/E 2025	-0.19x
Enterprise Value	69.74M 81M 65.49M 59.78M 112M 7.71B 113M 776M 302M 3.91B 304M 298M 12.94B	EV / Sales 2024	0.71x	EV / Sales 2025	0.68x
Free-Float	40.35%	Yield 2024 *	-	Yield 2025	-

Aug. 06	Biosynex hit by cyberattack, operational activity remains intact
Jun. 11	Triple update for Biosynex
Jun. 10	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
May. 25	Paris climbs on hopes of Middle East de-escalation
May. 25	Biosynex announces the divestment of its molecular biology business
May. 24	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
May. 07	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
May. 06	Biosynex SA Auditor Raises 'Going Concern' Doubt	CI
Apr. 21	Thales, Vivendi, Mercialys, GTT... stocks to watch today in Paris
Apr. 21	Biosynex postpones publication of annual accounts
Mar. 24	Abivax, Ekinops, Sanofi... stocks to watch today in Paris
Mar. 24	Observation period extended for Biosynex
Feb. 06	A Biosynex Subsidiary to Receive $1.8 Million Grant

24-10-23	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY	EQ
23-04-27	Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	AQ
23-04-13	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
23-03-15	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
23-01-31	Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement	AQ

Biosynex Stock

Stocks

ALBIO

FR0011005933

Medical Equipment, Supplies & Distribution

Valuation : Biosynex

Chart: Biosynex

Latest news : Biosynex

Press Releases : Biosynex

News in other languages : Biosynex

Quotes and Performance

Price Extremes

Managers and Directors : Biosynex

Latest insider transactions

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 day	-0.45%
1 week	-0.89%
Current month	-0.45%
1 month	-2.83%
3 months	-12.35%
6 months	-3.87%
Current year	+50.00%

1 week	0.89	0.92
1 month	0.89	1
Current year	0.56	1.57
1 year	0.46	1.57
3 years	0.46	10.9
5 years	0.46	28.78
10 years	0.46	30.38

Date	Insider	Type	Main position	Quantity	% Market Cap.
2/15/23	Elie Fraenckel	Buy	Director	2,500	0.0244%
2/15/23	Elie Fraenckel	Buy	Director	2,500	0.0244%
2/28/22	Larry Abensur	Buy	Chief Executive Officer	2,000	0.0180%

	2024	2025
Net sales	101M 117M 94.99M 86.71M 163M 11.18B 164M 1.13B 438M 5.67B 441M 432M 18.77B	95.19M 111M 89.38M 81.59M 153M 10.52B 154M 1.06B 412M 5.33B 415M 406M 17.66B
Net income	-43.33M -50.33M -40.69M -37.14M -69.77M -4.79B -70.27M -482M -188M -2.43B -189M -185M -8.04B	-58.22M -67.62M -54.67M -49.9M -93.75M -6.43B -94.42M -648M -252M -3.26B -254M -248M -10.8B
Net Debt	52.94M 61.48M 49.71M 45.37M 85.24M 5.85B 85.85M 589M 229M 2.97B 231M 226M 9.82B	53.19M 61.78M 49.94M 45.59M 85.65M 5.88B 86.26M 592M 230M 2.98B 232M 227M 9.87B